Holen Sie sich die Stockscreener-App
1.07
0.94%
0.01
Handel nachbörslich:
1.04
-0.03
-2.80%
Schlusskurs vom Vortag:
$1.06
Offen:
$1.04
24-Stunden-Volumen:
275.60K
Relative Volume:
0.56
Marktkapitalisierung:
$25.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.33M
KGV:
-1.6212
EPS:
-0.66
Netto-Cashflow:
$-13.21M
1W Leistung:
+2.88%
1M Leistung:
-27.70%
6M Leistung:
-0.93%
1J Leistung:
-13.01%
1-Tages-Spanne:
$1.02
$1.07
1-Wochen-Bereich:
$1.01
$1.07
52-Wochen-Spanne:
$0.8101
$2.10
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
Firmenname
Enlivex Therapeutics Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ENLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
1.07 | 25.28M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-02 | Bestätigt | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd Aktie (ENLV) Neueste Nachrichten
Applying Wyckoff theory to Enlivex Therapeutics Ltd. stockMarket Rally & Consistent Growth Equity Picks - Newser
Multi asset correlation models including Enlivex Therapeutics Ltd.Weekly Market Summary & Expert Approved Momentum Ideas - Newser
Measuring Enlivex Therapeutics Ltd.’s beta against major indices2025 Top Decliners & Low Risk Growth Stock Ideas - Newser
Understanding Enlivex Therapeutics Ltd.’s price movementQuarterly Risk Review & Weekly Market Pulse Alerts - Newser
Relative strength of Enlivex Therapeutics Ltd. in sector analysisQuarterly Market Summary & Daily Price Action Insights - Newser
Can technical indicators confirm Enlivex Therapeutics Ltd.’s reversalJuly 2025 Breakouts & Reliable Volume Spike Alerts - Newser
Applying big data sentiment scoring on Enlivex Therapeutics Ltd.July 2025 Gainers & Pattern Based Trade Signal System - Newser
Is it time to cut losses on Enlivex Therapeutics Ltd.2025 Year in Review & Expert-Curated Trade Recommendations - Newser
Volatility clustering patterns for Enlivex Therapeutics Ltd.2025 Institutional Moves & Accurate Entry/Exit Alerts - Newser
How to manage a losing position in Enlivex Therapeutics Ltd.2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - Newser
Is Enlivex Therapeutics Ltd. on track to beat earningsJuly 2025 Sector Moves & AI Based Trade Execution Alerts - khodrobank.com
Real time pattern detection on Enlivex Therapeutics Ltd. stockEarnings Miss & Smart Money Movement Tracker - Newser
Will Enlivex Therapeutics Ltd. benefit from geopolitical trendsBear Alert & Verified Momentum Watchlists - khodrobank.com
Is Enlivex Therapeutics Ltd. trending in predictive chart models2025 AllTime Highs & Technical Analysis for Trade Confirmation - Newser
How sensitive is Enlivex Therapeutics Ltd. to inflationIndex Update & AI Based Buy/Sell Signal Reports - khodrobank.com
Will Enlivex Therapeutics Ltd. rebound enough to break evenJuly 2025 Summary & Expert Approved Momentum Trade Ideas - Newser
When is the best time to exit Enlivex Therapeutics Ltd.Earnings Trend Report & Technical Buy Zone Confirmation - Newser
Will Enlivex Therapeutics Ltd. outperform the marketJuly 2025 Reactions & Free Reliable Trade Execution Plans - Newser
Identifying reversal signals in Enlivex Therapeutics Ltd.2025 Market Trends & Daily Growth Stock Investment Tips - Newser
How moving averages guide Enlivex Therapeutics Ltd. tradingWeekly Profit Report & Weekly Breakout Opportunity Watchlist - Newser
What earnings revisions data tells us about Enlivex Therapeutics Ltd.July 2025 Market Mood & High Accuracy Trade Signal Alerts - Newser
Aug Action: What is the next catalyst for Enlivex Therapeutics Ltd.Weekly Profit Recap & Capital Efficient Trading Techniques - khodrobank.com
Published on: 2025-09-02 02:11:50 - Newser
Why Enlivex Therapeutics Ltd. is moving todayPortfolio Gains Summary & Expert Approved Momentum Ideas - Newser
Will a bounce in Enlivex Therapeutics Ltd. offer an exitTrade Analysis Summary & Real-Time Buy Signal Notifications - Newser
What is the next catalyst for Enlivex Therapeutics Ltd.2025 Volatility Report & Accurate Entry and Exit Point Alerts - khodrobank.com
Is Enlivex Therapeutics Ltd.’s ROE strong enoughTrade Analysis Report & Risk Managed Investment Strategies - khodrobank.com
Will breakout in Enlivex Therapeutics Ltd. lead to full recoveryJuly 2025 Price Swings & Reliable Momentum Entry Alerts - Newser
How to build a dashboard for Enlivex Therapeutics Ltd. stockJuly 2025 Snapshot & Entry and Exit Point Strategies - Newser
Can Enlivex Therapeutics Ltd. Regain Lost Ground This Quarter2025 Technical Overview & Stock Portfolio Risk Control - beatles.ru
Momentum divergence signals in Enlivex Therapeutics Ltd. chartEarnings Performance Report & Weekly Sector Rotation Insights - Newser
Developing predictive dashboards with Enlivex Therapeutics Ltd. dataWeekly Investment Summary & AI Powered Trade Plan Recommendations - Newser
Is Enlivex Therapeutics Ltd. stock bottoming outJuly 2025 News Drivers & Expert Verified Stock Movement Alerts - Newser
Published on: 2025-08-31 03:52:09 - Newser
Key resistance and support levels for Enlivex Therapeutics Ltd.2025 Earnings Impact & Consistent Return Investment Signals - Newser
Using data filters to optimize entry into Enlivex Therapeutics Ltd.July 2025 Volume & Stepwise Swing Trade Plans - Newser
Quantitative breakdown of Enlivex Therapeutics Ltd. recent moveQuarterly Growth Report & Accurate Trade Setup Notifications - Newser
Can Enlivex Therapeutics Ltd. rally from current levels2025 Trading Volume Trends & Precise Trade Entry Recommendations - Newser
Finanzdaten der Enlivex Therapeutics Ltd-Aktie (ENLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):